COMPANY PROFILE

Nitric Bio

Explore full profile

Zero-emission nitric acid from air and water.

Bristol, United KingdomFounded 2006Biotech & Life Sciences

Valuation $50–100M Last recorded · 2006

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Nitric Bio

Founded in 2021 and based in British Columbia, Canada, Nitric Bio is a climate technology company focused on decarbonizing the heavy chemical industry.

The company is developing a process to produce zero-emission nitric acid. This method utilizes only air, water, and renewable electricity as inputs, positioning it as a clean alternative to the conventional Ostwald process. The traditional method is energy-intensive and a significant source of greenhouse gas emissions, as it relies on ammonia produced via the fossil-fuel-dependent Haber-Bosch process.

Nitric Bio’s core market is the agricultural sector, as approximately 80% of global nitric acid production is used to manufacture nitrogen fertilizers. By enabling the creation of 'green' fertilizer, the company offers a direct path for the agriculture industry to reduce its carbon footprint. Other addressable markets include the production of polymers and specialty chemicals where nitric acid is a key ingredient. The business model is geared towards decentralized, on-site production, which can reduce transportation costs, improve supply chain resilience, and allow for 'just-in-time' manufacturing tailored to consumer needs.

MoreLess Source: Dealroom company data

At a glance

Status: Closed
Founded: 2006
Headquarters: Bristol, United Kingdom
Employees: 2
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Machine, uk is8 life sciences
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	Jan 2012	$1M	—	Undisclosed	—
DEBT✓Debt	Jul 2010	$1.8M	—	Undisclosed	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Nitric Bio website traffic

Latest recorded traffic for Nitric Bio is 110 monthly website visits. Nitric Bio's team grew 0% over the past year.

Latest monthly visits110 1-year team growth0%

Monthly website visitsMay 2017–Apr 2018

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CCCalla Lily Clinical CareLeak-free vaginal drug delivery platform for fertility	London, United Kingdom	Operational	28	$4.6M	$4.2M
PMPinpoint MolecularMethodologies for extracting aggregated amyloid proteins	London, United Kingdom	Low Activity
MDMI:RNA DiagnosticsVeterinary diagnostic testing using microRNA biomarkers and AI	Whitburn, United Kingdom	Operational
IBIMU BiosciencesAI-powered platform decoding the immune system	London, United Kingdom	Operational
UNUntapAutomated wastewater surveillance for early disease detection.	London, United Kingdom	Operational
FEFerryxDeveloping Live Biotherapeutic Products for human and veterinary use	Bristol, United Kingdom	Operational
ELElevateMeAt-home blood tests with personalized AI-driven health insights	London, United Kingdom	Operational
MBMitra bioNon-invasive diagnostics for skincare and therapeutics development	London, United Kingdom	Operational